申请人:Abbott Laboratories
公开号:US06277850B1
公开(公告)日:2001-08-21
Pyrrolylquinoxalinediones of the formula I
and their tautomeric and isomeric forms, and their physiologically tolerated salts are described, where the variables have the following meaning:
R1 hydrogen, C1-C6-alkyl, substituted by hydroxyl or carboxyl,
R2 hydrogen, C1-C6-alkyl, C2-C6-alkenyl, C2-C6-alkynyl, a chlorine, fluorine or bromine atom, a trihalomethyl, cyano or nitro group or SO2—C1-C4-alkyl,
R3 COOH or a radical which can be hydrolyzed to the carboxyl group,
n 1 or 2.
公式I的吡咯基喹喔啉二酮及其互变异构和同分异构形式以及其生理耐受的盐已被描述,其中变量的含义如下:R1为氢、C1-C6-烷基,被羟基或羧基取代,R2为氢、C1-C6-烷基、C2-C6-烯基、C2-C6-炔基、氯、氟或溴原子、三卤甲基、氰基或硝基,或SO2—C1-C4-烷基,R3为COOH或可水解为羧基的基团,n为1或2。